These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34743376)

  • 1. High concentration of oxaliplatin may be a risk factor for vascular pain.
    Matsunuma S; Handa S; Yamamoto H; Okuyama K; Yoshimoto K; Kato Y
    J Clin Pharm Ther; 2022 Apr; 47(4):462-468. PubMed ID: 34743376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitors Ameliorate Oxaliplatin-induced Peripheral Neuropathy: Retrospective Analysis of Two Real-world Clinical Databases.
    Kobayashi A; Ikemura K; Wakai E; Kondo M; Okuda M
    Anticancer Res; 2023 Dec; 43(12):5613-5620. PubMed ID: 38030205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin induces prostaglandin E2 release in vascular endothelial cells.
    Matsunuma S; Handa S; Kamei D; Yamamoto H; Okuyama K; Kato Y
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):345-350. PubMed ID: 31243527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction for oxaliplatin-induced liver injury using patient-derived liver organoids.
    Tatsumi K; Wada H; Hasegawa S; Asukai K; Nagata S; Ekawa T; Akazawa T; Mizote Y; Okumura S; Okamura R; Ohue M; Obama K; Tahara H
    Cancer Med; 2024 Feb; 13(3):e7042. PubMed ID: 38400666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin, an Anticancer Agent, Causes Erectile Dysfunction in Rats due to Endothelial Dysfunction.
    Kataoka T; Mori T; Suzuki J; Kawaki Y; Kito Y; Hotta Y; Kawade Y; Maeda Y; Kimura K
    J Sex Med; 2021 Aug; 18(8):1337-1345. PubMed ID: 34281797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and toxicodynamic evaluation of oxaliplatin-induced neuropathy and hematological toxicity in rats.
    Ito Y; Kobuchi S; Shimizu R; Katsuyama Y
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):155-161. PubMed ID: 29164296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk Factors for Oxaliplatin-Induced Phlebitis and Venous Pain, and Evaluation of the Preventive Effect of Preheating with a Hot Compress for Administration of Oxaliplatin].
    Nakauchi K; Kawazoe H; Miyajima R; Waizumi C; Rokkaku Y; Tsuneoka K; Higuchi N; Fujiwara M; Kojima Y; Yakushijin Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(11):1397-400. PubMed ID: 26602398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
    Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
    Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processed aconite root and its active ingredient neoline may alleviate oxaliplatin-induced peripheral neuropathic pain.
    Suzuki T; Miyamoto K; Yokoyama N; Sugi M; Kagioka A; Kitao Y; Adachi T; Ohsawa M; Mizukami H; Makino T
    J Ethnopharmacol; 2016 Jun; 186():44-52. PubMed ID: 27038579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction of vascular pain due to drop-infusion of oxaliplatin (L-OHP) in peripheral vein with heated infusion route].
    Yatate M; Kimura M; Iwasaki Y; Kamura M; Yokoi M; Uchitani S; Mizumoto T; Matsushita H
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):589-91. PubMed ID: 22504683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intact oxaliplatin in plasma on a cold allodynia after multiple administrations in colorectal cancer model rats.
    Ito Y; Kobuchi S; Takeda M; Morimoto M
    Ann Palliat Med; 2020 Sep; 9(5):3000-3006. PubMed ID: 32692214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
    Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S
    BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions related to oxaliplatin (OHP).
    Brandi G; Pantaleo MA; Galli C; Falcone A; Antonuzzo A; Mordenti P; Di Marco MC; Biasco G
    Br J Cancer; 2003 Aug; 89(3):477-81. PubMed ID: 12888815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Search for Factors Related to Vascular Pain Expression upon Administration of Oxaliplatin into a Peripheral Vein].
    Takagi A; Yonemoto N; Aoyama Y; Touma Y; Kajiwara M; Watanabe K; Miyazaki Y; Koinuma M
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):887-9. PubMed ID: 26197757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEA-OXA Mitigates Oxaliplatin-Induced Painful Neuropathy through NF-κB/Nrf-2 Axis.
    Campolo M; Lanza M; Paterniti I; Filippone A; Ardizzone A; Casili G; Scuderi SA; Puglisi C; Mare M; Memeo L; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
    Liang J; Tian XF; Yang W
    World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer.
    Ohta H; Hayashi T; Murai S; Shiouchi H; Ando Y; Kumazawa S; Ito K; Ikeda Y; Matsuoka H; Maeda K; Kawada K; Yasuda K; Yamada S
    Cancer Chemother Pharmacol; 2017 May; 79(5):1021-1029. PubMed ID: 28391355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin infusion-related venous pain: prevention by simultaneous intravenous fluids.
    van Ravensteijn S; van Merrienboer B; van Asten S; Pruijt J; Hilbink M; Tol J
    BMJ Support Palliat Care; 2021 Jun; 11(2):226-229. PubMed ID: 32451327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer.
    Seki K; Senzaki K; Tsuduki Y; Ioroi T; Fujii M; Yamauchi H; Shiraishi Y; Nakata I; Nishiguchi K; Matsubayashi T; Takakubo Y; Okamura N; Yamamori M; Tamura T; Sakaeda T
    Int J Med Sci; 2011 Mar; 8(3):210-5. PubMed ID: 21448307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for oxaliplatin-induced vascular pain in patients with colorectal cancer and comparison of the efficacy of preventive methods.
    Suga Y; Ikeda N; Maeda M; Staub AY; Shimada T; Yonezawa M; Kitade H; Katsura H; Okada M; Ishizaki J; Sai Y; Matsushita R
    J Pharm Health Care Sci; 2018; 4():18. PubMed ID: 30094053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.